PT Pyridam Farma Tbk
PYFA
Rank in Stocks
#20965
PT Pyridam Farma Tbk, an Indonesian-based enterprise, specializes in the... PT Pyridam Farma Tbk, an Indonesian-based enterprise, specializes in the development, production, and distribution of a broad spectrum of health-related products. Its offerings encompass pharmaceuticals, antibiotics, essential vitamins, dietary supplements, and traditional herbal remedies. The company's operations are divided into two main segments: Pharmaceutical Products and Contract Manufacturing Services, and Medical Device Products. Within its medical device division, the firm provides a variety of instruments and consumables. These include clinical waste management items, collection swabs and tubes, innerbox DCA, KF94 masks, parafilm, PCR extraction kits and their accompanying machinery, specimen bags, sterile containers, and tube stoppers. Furthermore, PT Pyridam Farma markets a diverse collection of skincare products, such as Arosa gel, A-Stark Gel, Hymen gel, Pyderen Emulsion, Tonic Bust Emulsion, Calmosan Cream, and Di-Herb gel. Its pharmaceutical portfolio addresses numerous therapeutic areas, including digestive and metabolic health, blood and blood-forming organ conditions, cardiovascular disorders, dermatological ailments, genitourinary system and sex hormone regulation, systemic corticosteroids, systemic antibacterial treatments, sensory organ issues, as well as musculoskeletal, nervous, and respiratory system conditions. Beyond medicinal lines, the company also develops and sells dietary supplements and preventive consumer health items, notably energy drinks and various healthy ready-to-consume beverages. A key area of its strategic focus involves conducting extensive research and development in biotechnology, life sciences, and medical science. Established in 1976, PT Pyridam Farma Tbk is headquartered in Jakarta, Indonesia.
Share Price
$0.00670277
Last synced: 2026-11-10
Market Cap
$75.32M
Change (1 day)
2.54%
Change (1 year)
-79.80%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade PT Pyridam Farma Tbk (PYFA)
Category
Healthcare
P/S ratio for PT Pyridam Farma Tbk (PYFA)
P/S ratio as of November 2026 TTM: 0.50
According to PT Pyridam Farma Tbk's latest financial reports and stock price, its current price-to-sales ratio (TTM) is 0.50. At the end of 2025 the company had a P/S ratio of 1.94.
P/S ratio history for PT Pyridam Farma Tbk from 2005 to 2026
P/S ratio at the end of each year
| Year | P/S Ratio | Change |
|---|---|---|
| 2026 (TTM) | 0.50 | -74.26% |
| 2025 | 1.94 | 108.79% |
| 2024 | 0.93 | 4.95% |
| 2023 | 0.88 | -70.65% |
| 2022 | 3.01 | -24.89% |
| 2021 | 4.01 | -54.20% |
| 2020 | 8.76 | 1,942.58% |
| 2019 | 0.43 | 214,300.00% |
| 2018 | 0.00 | -99.99% |
| 2017 | 2.20 | -80.88% |
| 2016 | 11.48 | 79.05% |
| 2015 | 6.41 | -99.16% |
| 2014 | 766.06 | -82.93% |
| 2013 | 4.49K | 170,309.40% |
| 2012 | 2.63 | -100.00% |
| 2011 | 147.76K | 28.62% |
| 2010 | 114.88K | 8.29% |
| 2009 | 106.09K | 205,196,232.11% |
| 2008 | 0.05 | 0.00% |
| 2007 | 0.00 | 0.00% |
| 2006 | 0.00 | -100.00% |
| 2005 | 0.14 | 0.00% |
P/S ratio for similar companies or competitors
| Company | P/S Ratio | P/S Ratio Difference | Country |
|---|---|---|---|
| 2.82 | 464.78% |
DE
|
|
| 3.11 | 523.25% |
DE
|
|
| 2.26 | 353.30% |
JP
|
|
| 9.32 | 1,766.44% |
CH
|
|
| 2.73 | 446.94% |
IL
|
Questions about PT Pyridam Farma Tbk's P/S ratio
What is PT Pyridam Farma Tbk's P/S ratio?
PT Pyridam Farma Tbk's P/S ratio is 0.50, as of Nov 2026.
What was PT Pyridam Farma Tbk's P/S ratio in 2025?
In 2025, PT Pyridam Farma Tbk's P/S ratio was 1.94, compared with 0.93 in 2024.
How has PT Pyridam Farma Tbk's P/S ratio changed since 2020?
From 2020 to 2025, PT Pyridam Farma Tbk's P/S ratio was highest in 2020 (8.76) and lowest in 2023 (0.88).
How does PT Pyridam Farma Tbk's P/S ratio compare with similar companies?
PT Pyridam Farma Tbk's P/S ratio (0.50) is lower than that of all 5 similar companies listed above. The highest among them is Galderma Group AG, with 9.32.